We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$149M
AUM Growth
-$355K
Cap. Flow
-$5.69M
Cap. Flow %
-3.82%
Top 10 Hldgs %
60.16%
Holding
219
New
19
Increased
55
Reduced
131
Closed
11

Top Buys

Rank Stock Value
1
SNCR
Synchronoss Technologies
SNCR
+$1.2M
2
JBL icon
Jabil
JBL
+$334K
3
LULU icon
lululemon athletica
LULU
+$248K
4
HUBB icon
Hubbell
HUBB
+$229K
5
TJX icon
TJX Companies
TJX
+$223K

Top Sells

Rank Stock Value
1
CBUS icon
Cibus
CBUS
+$1.76M
2
RPRX icon
Royalty Pharma
RPRX
+$1.56M
3
SSPY icon
Syntax Stratified LargeCap ETF
SSPY
+$972K
4
BBWI icon
Bath & Body Works
BBWI
+$456K
5
ATVI
Activision Blizzard
ATVI
+$334K

Sector Composition

Rank Sector Weight
1 Healthcare 21.2%
2 Technology 8.1%
3 Consumer Staples 7.12%
4 Consumer Discretionary 6.29%
5 Industrials 4.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
126
Merck
MRK
$322B
$246K 0.17%
2,254
+126
+6% +$13.1K
HAS icon
127
Hasbro
HAS
$13.2B
$245K 0.17%
4,808
+1,286
+37% +$65K
HPE icon
128
Hewlett Packard
HPE
$63.4B
$245K 0.16%
14,430
+235
+2% +$3.83K
MOH icon
129
Molina Healthcare
MOH
$10.2B
$245K 0.16%
677
-148
-18% -$52.2K
STLD icon
130
Steel Dynamics
STLD
$36B
$245K 0.16%
2,071
-325
-14% -$36.2K
RJF icon
131
Raymond James Financial
RJF
$33.8B
$244K 0.16%
2,188
-126
-5% -$13K
SNA icon
132
Snap-on
SNA
$21.2B
$243K 0.16%
843
-100
-11% -$27K
REGN icon
133
Regeneron Pharmaceuticals
REGN
$78.5B
$243K 0.16%
277
-5
-2% -$4.12K
KDP icon
134
Keurig Dr Pepper
KDP
$42.3B
$243K 0.16%
7,291
-87
-1% -$2.71K
ABBV icon
135
AbbVie
ABBV
$443B
$243K 0.16%
1,567
+9
+0.6% +$1.31K
BF.B icon
136
Brown-Forman Class B
BF.B
$13.2B
$243K 0.16%
4,252
+425
+11% +$24.3K
ETN icon
137
Eaton
ETN
$161B
$243K 0.16%
1,007
-33
-3% -$7.28K
AIG icon
138
American International
AIG
$41.7B
$242K 0.16%
3,570
-561
-14% -$35.7K
OKE icon
139
Oneok
OKE
$57.2B
$241K 0.16%
3,429
-371
-10% -$24.9K
STZ icon
140
Constellation Brands
STZ
$22.2B
$241K 0.16%
996
+42
+4% +$9.99K
HIG icon
141
Hartford Financial Services
HIG
$38.9B
$240K 0.16%
2,991
-451
-13% -$34K
GILD icon
142
Gilead Sciences
GILD
$162B
$240K 0.16%
2,964
-86
-3% -$6.69K
UNH icon
143
UnitedHealth
UNH
$376B
$240K 0.16%
455
-91
-17% -$48.5K
TSLA icon
144
Tesla
TSLA
$1.23T
$239K 0.16%
962
-25
-3% -$5.94K
AEP icon
145
American Electric Power
AEP
$69.6B
$239K 0.16%
2,939
-226
-7% -$17.5K
BMY icon
146
Bristol-Myers Squibb
BMY
$133B
$239K 0.16%
4,652
+844
+22% +$44.3K
NEE icon
147
NextEra Energy
NEE
$181B
$238K 0.16%
3,921
+234
+6% +$13.3K
HUM icon
148
Humana
HUM
$43.7B
$238K 0.16%
520
-45
-8% -$22.2K
DTE icon
149
DTE Energy
DTE
$29.5B
$238K 0.16%
2,156
-247
-10% -$25.3K
JNJ icon
150
Johnson & Johnson
JNJ
$618B
$237K 0.16%
1,515
+69
+5% +$10.6K
4 5
6
7 8

Similar funds

MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
NCM
Northwest Capital Management Lake Oswego, Oregon $23.1M AUM 13.6% 1-Year Est. Return
FFGIM
Founders Fund Growth II Management San Francisco, California $23.7M AUM
PIM
Profit Investment Management North Bethesda, Maryland $24.7M AUM 21.29% 1-Year Est. Return
HFG
Harborfront Financial Group Ludington, Michigan $13.4M AUM
SWM
Stark Wealth Management Bethlehem, Pennsylvania $26.6M AUM 23.19% 1-Year Est. Return
ICM
Infini Capital Management Central, Hong Kong $12.4M AUM 53.5% 1-Year Est. Return
SM
Southport Management Wilson, Wyoming $28.6M AUM 41.61% 1-Year Est. Return

Vantage Consulting Group's Q4 2023 Portfolio in Review

As of Q4 2023, Vantage Consulting Group held 219 positions worth $149M, down 0.24% from $149M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Vantage Consulting Group withdrew a net $5.69M in Q4 2023, closing 11 positions and reducing 131 holdings. Its most notable exit was Royalty Pharma, an estimated $1.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, Vantage Consulting Group opened a new position in Synchronoss Technologies worth $1.53M.

  • Vantage Consulting Group's largest Q4 2023 buy was Synchronoss Technologies: 245,947 shares worth $1.53M.
  • Vantage Consulting Group added most to TJX Companies in Q4 2023, an estimated $223K increase.
  • Vantage Consulting Group's biggest Q4 2023 reduction was Cibus, cutting an estimated $1.76M.
  • Vantage Consulting Group fully exited Royalty Pharma in Q4 2023, selling an estimated $1.56M.
  • Vantage Consulting Group's ten largest holdings make up 60% of its $149M portfolio in Q4 2023.
  • Vantage Consulting Group opened 19 new positions and closed 11 in Q4 2023.
  • Vantage Consulting Group's portfolio value fell 0.24% quarter-over-quarter to $149M.

Based on Vantage Consulting Group's 13F filing for Q4 2023, filed 14 Feb 2024.